By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AstraZeneca Canada Inc. 

1004 Middlegate Road

Mississauga  Ontario  L4Y 1M4  Canada
Phone: 905-277-7111 Fax: 905-270-3248


Company News
AstraZeneca Canada (AZN) Release: PEGASUS-TIMI 54 Study Shows That Long-Term Treatment With BRILINTA Reduced Thrombotic Cardiovascular Events In Patients With A History Of Heart Attack 3/16/2015 6:56:06 AM
AstraZeneca Canada Inc. (AZN) Release: Lose The Sugar - A New Approach In The Fight Against Type 2 Diabetes 12/17/2014 9:57:56 AM
Banting & Best Diabetes Centre Receives $1 Million Investment From AstraZeneca Canada Inc. (AZN) 12/10/2014 7:33:35 AM
AstraZeneca Canada Inc. (AZN) Release: Real-World Evidence Shows Importance of Treatment Choice in Risk of COPD Related Pneumonia 6/17/2013 9:01:33 AM
NEOMED and AstraZeneca Canada Inc. (AZN) Broaden Strategic Alliance in Discovery Research, Share Compound Libraries 5/30/2013 9:31:15 AM
AstraZeneca Canada Inc. (AZN) Release: Real-World Study Comparing Commonly Prescribed COPD Medicines Shows Choice of Treatment Has Impact on Patient Outcomes 3/25/2013 9:10:33 AM
AstraZeneca Canada Inc. (AZN) Release: Mood App Designed for Youth by Youth Launches Today at Sandbox Conference 1/17/2013 10:09:06 AM
CardioComm Solutions Inc. (CCG) Enters Into Equipment Purchase Agreement with AstraZeneca Canada Inc. (AZN) 11/29/2011 6:55:49 AM
STI Enables AstraZeneca Canada Inc. (AZN) to Allow Ongoing Choice for NEXIUM(R) 9/9/2011 12:09:50 PM
AstraZeneca Canada Inc. (AZN) Expands Product Portfolio to Include Vaccines 8/18/2009 11:56:28 AM